CervoMed (CRVO) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CRVO Stock Alerts $23.82 -1.17 (-4.68%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCervoMed Inc.wsj.com - April 19 at 2:46 PMCRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24benzinga.com - April 15 at 3:37 PMFY2024 EPS Estimates for CervoMed Inc. Raised by Zacks Small Cap (NASDAQ:CRVO)marketbeat.com - April 12 at 6:40 AMZacks Small Cap Weighs in on CervoMed Inc.'s Q1 2024 Earnings (NASDAQ:CRVO)marketbeat.com - April 11 at 7:10 AMCervoMed shares target raised by Canaccord on positive trial outlookuk.investing.com - April 10 at 6:49 PMCRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24…finance.yahoo.com - April 10 at 1:49 PMCanaccord Genuity Group Increases CervoMed (NASDAQ:CRVO) Price Target to $65.00marketbeat.com - April 8 at 8:29 AMCervoMed: H2 2024 Data For DLB Program A Major Inflection Pointseekingalpha.com - April 3 at 5:08 AMCervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updatesglobenewswire.com - April 1 at 8:00 AMCervoMed secures $50 million in private placementuk.investing.com - March 30 at 2:14 PMCervoMed to Participate in Upcoming Investor Conferencesglobenewswire.com - March 28 at 4:05 PMCervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investorsglobenewswire.com - March 28 at 8:30 AMCervoMed (CRVO) Set to Announce Quarterly Earnings on Fridaymarketbeat.com - March 21 at 7:37 AMShort Interest in CervoMed Inc. (NASDAQ:CRVO) Declines By 17.5%marketbeat.com - March 15 at 11:36 PMAdage Capital Partners GP L.L.C. Acquires Shares of 199,347 CervoMed Inc. (NASDAQ:CRVO)marketbeat.com - March 12 at 5:54 AMCervoMed Inc.'s (NASDAQ:CRVO): Top Key Executive Sylvie Gregoire is the most bullish insider, and their stock value gained 29% last weekfinance.yahoo.com - March 9 at 12:44 PMCervoMed reports promising dementia treatment trial resultsuk.investing.com - March 7 at 11:14 PMCervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024globenewswire.com - March 5 at 8:00 AMCervoMed Inc. (NASDAQ:CRVO) Sees Large Growth in Short Interestmarketbeat.com - March 3 at 9:39 AMCervoMed (CRVO) Price Target Increased by 97.06% to 34.17msn.com - February 25 at 1:09 AMCervoMed to Participate in the BIO CEO and Investor Conferencefinance.yahoo.com - February 21 at 8:56 AMCervoMed to Participate in the BIO CEO and Investor Conferenceglobenewswire.com - February 21 at 8:00 AMCanaccord Genuity Group Begins Coverage on CervoMed (NASDAQ:CRVO)marketbeat.com - February 15 at 8:26 AMCervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodiesfinance.yahoo.com - February 12 at 1:25 PMCervoMed appoints drug development veteran Dr. Joshua Boger as Chairman of the Boardproactiveinvestors.com - February 9 at 4:10 PMCervoMed Appoints New Chair and Presents at Conference 67msn.com - February 8 at 8:46 AMCervoMed Names Joshua Boger as New Board Chairmsn.com - February 8 at 8:46 AMCervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Boardfinance.yahoo.com - February 7 at 12:45 PMCervoMed to Participate in the Emerging Growth Conference 67finance.yahoo.com - February 5 at 8:51 AMCervoMed Signs Key Material Definitive Agreementmsn.com - February 3 at 8:33 AMCervoMed Announces Executive Leadership Agreements Updatemsn.com - February 3 at 8:33 AMCervoMed to Participate in the Emerging Growth Conference 66finance.yahoo.com - January 5 at 12:14 PMWe're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Ratefinance.yahoo.com - November 17 at 8:38 AMCRVO: Publications Highlight Neflamapimod as Potential Disease-Modifying Therapy for Major Dementias…finance.yahoo.com - November 16 at 3:50 PMCervoMed Inc.: CervoMed Reports Third Quarter 2023 Financial Results and Business Highlightsfinanznachrichten.de - November 13 at 11:46 AMCervoMed Reports Third Quarter 2023 Financial Results and Business Highlightsfinance.yahoo.com - November 13 at 11:46 AMCervoMed Inc CRVOmorningstar.com - November 10 at 9:10 PMCRVO: New Data from Phase 2a Trial Presented at CTAD…finance.yahoo.com - October 30 at 3:44 PMCervoMed Announces Oral Presentation at CTAD 2023 Highlighting Learnings from Phase 2a Which Optimized the Design of the Phase 2b Clinical Study of Neflamapimod in Dementia with Lewy Bodiesfinance.yahoo.com - October 25 at 6:09 PMCervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major Dementiasfinance.yahoo.com - October 24 at 9:45 AMCervoMed Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy Bodiesfinance.yahoo.com - October 18 at 7:37 AMCervoMed to Present at the 2023 Roth Healthcare Opportunities Conferencefinance.yahoo.com - October 5 at 9:30 AMCRVO: Publication in Neurology Highlights Correlation Between ptau181 Level and Response to Neflamapimod…msn.com - September 18 at 6:18 PMCRVO: Publication in Neurology Highlights Correlation Between ptau181 Level and Response to Neflamapimod…finance.yahoo.com - September 18 at 6:18 PMCervoMed to Present at H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 4:52 PMmarketbeat.com - August 18 at 9:36 AM Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details CRVO Media Mentions By Week CRVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVO News Sentiment▼-1.000.32▲Average Medical News Sentiment CRVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVO Articles This Week▼11▲CRVO Articles Average Week Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMAB News IXHL News GLSI News RGLS News CAPR News RZLT News ACET News KPTI News PRQR News SCPH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
